KER-0001

N/A

Report date: 2025/06/11 10:31:27

Base Information

Drug NameKER-0001
Drug Alias NameMRI agent (Kereos)alpha-v/beta-3 integrin targeted MRI agent (Kereos)KER-0001KI-0001KI-001
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKereos Inc
China Registration ClassN/A

Develop Information

Active CompaniesKereos Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A